What the FDA labels say about taking them together
Basiliximab and belatacept
Belatacept's FDA label of July 28, 2021 names basiliximab in its warnings and precautions section; the basiliximab label PlainMeds reads does not name belatacept. The belatacept label: “Rejection and Graft Loss with Corticosteroid Minimization In postmarketing experience, use of NULOJIX in conjunction with basiliximab induction, MMF, and corticosteroid minimization to 5 mg per day between Day 3 and …”
Check it at the source: the basiliximab FDA label on DailyMed (effective December 12, 2025, Novartis Pharmaceuticals Corporation); the belatacept FDA label on DailyMed (effective July 28, 2021, E.R. Squibb & Sons, L.L.C.).
What does the basiliximab label say about belatacept?
Basiliximab's label (effective December 12, 2025) does not name belatacept in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Simulect), Novartis Pharmaceuticals Corporation, effective December 12, 2025 (SPL set 1af01887-b69d-444b-91ed-ebfe12784440), via openFDA; the full label on DailyMed
What does the belatacept label say about basiliximab?
Belatacept label, warnings and precautionsRejection and Graft Loss with Corticosteroid Minimization In postmarketing experience, use of NULOJIX in conjunction with basiliximab induction, MMF, and corticosteroid minimization to 5 mg per day between Day 3 and Week 6 post-transplant was associated with an increased rate and grade of acute rejection, particularly Grade III rejection.
Source: FDA drug label (NULOJIX), E.R. Squibb & Sons, L.L.C., effective July 28, 2021 (SPL set c16ac648-d5d2-9f7d-8637-e2328572754e), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Basiliximab | Belatacept | |
|---|---|---|
| Labeled for | Organ transplant rejection | Organ transplant rejection |
| Boxed warning | Yes | Yes |
| Pharmacy cost (NADAC) | n/a | n/a |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once